Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1096629.RAcIWDebu_gYW9ogJI7Sth8A5uN5UYeqCcnb5dj49Hv2Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1096629.RAcIWDebu_gYW9ogJI7Sth8A5uN5UYeqCcnb5dj49Hv2Y130_assertion type Assertion NP1096629.RAcIWDebu_gYW9ogJI7Sth8A5uN5UYeqCcnb5dj49Hv2Y130_head.
- NP1096629.RAcIWDebu_gYW9ogJI7Sth8A5uN5UYeqCcnb5dj49Hv2Y130_assertion description "[This study showed that pathological hypoxia (<0.5% O2) increased the expression of androgen receptor (AR) target genes such as prostate-specific antigen (PSA) and kallikrein-related peptidase 2 in LNCaP human prostate cancer cells by modifying the quantity and activity of related Jumonji C domain-containing histone demethylases (JMJDs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1096629.RAcIWDebu_gYW9ogJI7Sth8A5uN5UYeqCcnb5dj49Hv2Y130_provenance.
- NP1096629.RAcIWDebu_gYW9ogJI7Sth8A5uN5UYeqCcnb5dj49Hv2Y130_assertion evidence source_evidence_literature NP1096629.RAcIWDebu_gYW9ogJI7Sth8A5uN5UYeqCcnb5dj49Hv2Y130_provenance.
- NP1096629.RAcIWDebu_gYW9ogJI7Sth8A5uN5UYeqCcnb5dj49Hv2Y130_assertion SIO_000772 23884959 NP1096629.RAcIWDebu_gYW9ogJI7Sth8A5uN5UYeqCcnb5dj49Hv2Y130_provenance.
- NP1096629.RAcIWDebu_gYW9ogJI7Sth8A5uN5UYeqCcnb5dj49Hv2Y130_assertion wasDerivedFrom befree-2016 NP1096629.RAcIWDebu_gYW9ogJI7Sth8A5uN5UYeqCcnb5dj49Hv2Y130_provenance.
- NP1096629.RAcIWDebu_gYW9ogJI7Sth8A5uN5UYeqCcnb5dj49Hv2Y130_assertion wasGeneratedBy ECO_0000203 NP1096629.RAcIWDebu_gYW9ogJI7Sth8A5uN5UYeqCcnb5dj49Hv2Y130_provenance.